Product Information

DULOXETINE HCL DR 30 MG CAP is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0988 per EA under NDC 67877026410. Its NADAC has been published 351 times since Mar 4, 2020.

FDA first approved this application on Aug 26, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DULOXETINE HCL DR 30 MG CAP

Duloxetine
$0.0988per EA

Strength

30 mg/1

NDC

67877026410

Classification

Generic

Dosage Form

CAPSULE, DELAYED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

DULOXETINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA203197

FDA Approved

8/26/2015

TE Code

AB

On Market Since

5/1/2012

Pharmacological Classes

Norepinephrine Uptake Inhibitors
Serotonin Uptake Inhibitors
Serotonin and Norepinephrine Reuptake Inhibitor

Price Statistics

The NADAC for DULOXETINE HCL DR 30 MG CAP has been published 351 times since Mar 4, 2020, and over the history we have for it it has declined 38.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0988 per EA
All-time high$0.1618 (Mar 11, 2020)
All-time low$0.0696 (May 22, 2024)
52-week high$0.1058
52-week low$0.0781
Median price$0.1006
Average price$0.1032
Largest weekly change+25.8% (Mar 17, 2021)
Weeks tracked351
Tracking sinceMar 4, 2020

Price History

1W

-0.6%

1M

-3.5%

3M

-6.6%

6M

+0.4%

1Y

+26.0%

3Y

-0.0%

5Y

-12.0%

All

-38.9%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DULOXETINE HCL DR 30 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DULOXETINE HCL DR 30 MG CAP, manufactured by Ascend Laboratories, LLC, is $0.0988 per EA (NDC 67877026410), effective Nov 18, 2026.

How has the price of DULOXETINE HCL DR 30 MG CAP changed over time?

Over the history we have for it, the NADAC for DULOXETINE HCL DR 30 MG CAP has declined 38.9%. It has been tracked across 351 weekly CMS publications since Mar 4, 2020.

What are the highest and lowest recorded NADAC prices for DULOXETINE HCL DR 30 MG CAP?

Since Mar 4, 2020, the NADAC for DULOXETINE HCL DR 30 MG CAP has ranged from a low of $0.0696 (May 22, 2024) to a high of $0.1618 (Mar 11, 2020), with a median of $0.1006 per EA.

Are there cheaper alternatives to DULOXETINE HCL DR 30 MG CAP?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DULOXETINE HCL DR 30 MG CAP, is $0.0782 per EA — about 21% below DULOXETINE HCL DR 30 MG CAP.

Who manufactures DULOXETINE HCL DR 30 MG CAP?

DULOXETINE HCL DR 30 MG CAP (NDC 67877026410) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.